Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Working Capital/Sales

    Back to All Ratios
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 2.762.432.211.624.24

What is the latest Working Capital/Sales ratio of WINDLAS BIOTECH ?

The latest Working Capital/Sales ratio of WINDLAS BIOTECH is 2.76 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20252.76
Mar20242.43
Mar20232.21
Mar20221.62
Mar20214.24

How is Working Capital/Sales of WINDLAS BIOTECH Trending?

Years Working Capital/Sales % Change
Mar2025 2.76
13.58
Mar2024 2.43
9.95
Mar2023 2.21
36.42
Mar2022 1.62
-61.79
Mar2021 4.24 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Working Capital/Sales ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,653.0 Cr -0.5% -2.4% 0.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.5%

-2.4%

0.7%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses